When and How to Use Thromboelastography (TEG) in Preclinical Studies
|
|
Thromboelastography (TEG) is often used to measure clot strength, diagnose and quantify fibrinolysis, as well as help diagnose platelet dysfunction and hypercoagulability. TEG analysis is utilized in preclinical studies targeting bleeding disorders and platelet dysfunction, and can add valuable information in drug development focused on hematology and coagulation. Want to know more? Our scientific poster discusses the various benefits, challenges, and methods associated with the use of TEG in preclinical studies, including a case study. |
Renal Impairment Study Designs Trends, Optimization, Adaptive Approach. A Review.
Use of Thromboelastography (TEG) in Preclinical Studies
Development of an IL-31-Induced Pruritus Model in Cynomolgus Monkeys
Effect of Housing on Stress-Related Parameters in NHPs
Detection of Peripheral Blood Foxp3+ Regulatory T Cell Population in a Preclinical Setting
Translatability of Non-Human Primate Cytokine Data to In-Life Parameters in Nonclinical